Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease

Limited data are available regarding optimal treatment for refractory Mycobacterium avium complex-pulmonary disease (MAC-PD). We evaluated outcomes of inhaled amikacin (AMK) with clofazimine (CFZ) regimens as an add-on salvage therapy for refractory MAC-PD. We retrospectively analyzed 52 patients wi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Kim, Bo-Guen, Kim, Hojoong, Kwon, O. Jung, Huh, Hee Jae, Lee, Nam Yong, Baek, Sun-Young, Sohn, Insuk, Jhun, Byung Woo
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565500/
https://ncbi.nlm.nih.gov/pubmed/32937940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092968
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi